Biopsy Devices-Pipeline Insight and Competitive Landscape, 2022
Medical Pipeline (24 Hours) I 2022-07-01 I 60 Pages I DelveInsight
DelveInsight's, "Biopsy Devices-Pipeline Insight and 2022," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in biopsy devices pipeline landscape. Significant increase in incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Moreover, rise in awareness on diagnosis of chronic diseases fosters the demand for integrated biopsy technologies such as stereotactic-guided biopsy.
This reports provides a detailed study of the emerging biopsy devices along with competitive landscape to help better understand the market.
Geography Covered
- Global coverage
Biopsy Devices Overview
Biopsy Devices: Understanding
Biopsy devices are instruments that aid in the removal of tissue samples from the body. These samples are collected in order to examine it more closely.
When a Biopsy is needed?
- A mammogram shows a lump or mass, indicating the possibility of breast cancer
- A mole on the skin has changed shape recently and melanoma is possible
- A person has chronic hepatitis and it's important to know if cirrhosis is present
Biopsy Devices Competitive Assessment
This segment of the biopsy devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Product Type
Biopsy devices pipeline report is segmented based on product type such as core biopsy devices, aspiration biopsy needles and vacuum assisted biopsy devices.
?
- Product Technique
Based on the technology biopsy devices are of various types:
1. Ultrasound-guided Biopsy
2. Stereotactic-guided Biopsy
3. MRI-guided Biopsy
The biopsy device pipeline assessment covers the entire types of these techniques.
- Product Application
The biopsy devices are used in breast biopsy, lung biopsy, colorectal biopsy and prostate biopsy.
- Major Players in Biopsy Devices
There are approx. 20+ key companies which are developing the products for biopsy devices.
- 3D Biopsy Device: 3DBiopsy, Inc.
3DBiopsy is developing a new variable biopsy device, capable of taking a prostate specimen up to 2 to 5 cm in length, along with a biopsy needle that retrieves over 90% of the tissue sampled. The current biopsy devices take short (average 12 mm) fragmented specimens which miss cancers in 30% and mischaracterize the tumor aggressiveness in up to 50%. Patients undergoing MRI targeted fusion biopsy also require additional sampling due to the inadequacy of the shorter specimens. The Company's device will sample both peripheral and anterior zones and is capable of completely encompassing regions of interest when MRI fusion is performed.
- The OsteoAccess System: ActuatedMedical
Actuated Medical developed the OsteoAccess System to assist clinicians in bone marrow biopsy and aspiration procedures. The System uses controlled, micron-scale needle vibration to reduce the penetration force enabling easier cortical bone access.
Further product details are provided in the report..
?
Biopsy Devices: Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations
Biopsy Devices: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of biopsy devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
- In February 2019, University of Cambridge and Cambridge University Hospitals (CUH) researcher and urologist developed the CamProbe as a prototype to take safer prostate biopsies. The device is in the clinical stage.
- In June, 2019 the first of its kind "virtual biopsy" devices has been created by Rutgers University scientist. It uses sound vibrations and pulses of near-infrared light that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
Further commercial activities are provided in the report..
Biopsy Devices: Reimbursement
- US
Since January 2003, Medicare covers percutaneous image-guided breast biopsy using stereotactic or ultrasound imaging for a radiographic abnormality that is nonpalpable and is graded as a BIRADS III, IV, or V. Palpable Breast Lesions Effective January 1, 2003, Medicare covers percutaneous image guided breast biopsy using stereotactic or ultrasound imaging for palpable lesions that are difficult to biopsy using palpation alone.
Further information is provided in the report..
?
Report Highlights
- Extensive coverage of the biopsy devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of biopsy devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Biopsy Devices Report Insights
- Biopsy Devices - Pipeline Analysis
- Biopsy Devices - Unmet Need
- Biopsy Devices - Market Dynamics
- Biopsy Devices - Future Perspectives and Conclusion
- Biopsy Devices - Analyst Views
?
Key Questions
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of biopsy devices under development?
- What are market-entry and market expansion strategies in biopsy devices?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product's current stage of development, territory and estimated launch date?
1. Key Insights
2. Biopsy Devices: Snapshot
3. Biopsy Devices
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism
4. Biopsy Devices: Competitive Assessment
4.1. Assessment by Product Type
4.1.1. Core biopsy devices
4.1.2. Aspiration biopsy needles
4.1.3. Vacuum assisted biopsy devices
4.2. Assessment by Technique
4.2.1. Ultrasound-guided Biopsy
4.2.2. Stereotactic-guided Biopsy
4.2.3. MRI-guided Biopsy
4.3. Assessment by Application
4.3.1. Breast biopsy
4.3.2. Lung biopsy
4.3.3. Colorectal biopsy
4.3.4. Prostate biopsy
4.4. Assessment by Company
4.4.1. 3DBiopsy, Inc
4.4.1.1. 3D Biopsy Device: 3DBiopsy, Inc.
4.4.1.1.1. Product Information
4.4.1.1.2. Research and Development
4.4.1.1.3. Patent Details
4.4.1.1.4. Regulatory Milestone
4.4.2. ActuatedMedical
4.4.2.1. The OsteoAccess System: ActuatedMedical
4.4.2.1.1. Product Information
4.4.2.1.2. Research and Development
4.4.2.1.3. Patent Details
4.4.2.1.4. Regulatory Milestone
*More Companies and products would be added in the final report
5. Biopsy Devices: Competitive Benchmarking : By Company
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations
6. Biopsy Devices - Commercialization Activity
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthrough
6.5. Literature Studies
6.6. KOL Views
7. Biopsy Devices: Regulatory
7.1. US
7.2. Europe
7.3. Japan
8. Biopsy Devices: Reimbursement
8.1. Case Study - US
8.2. Case Study - Europe
Case Study -Japan
9. Biopsy Devices: Market Dynamics
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers
10. DelveInsight's Analytical Perspective
10.1. PEST Analysis
10.2. Future Growth Perspectives
11. Conclusion
12. Appendix
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research
13. Bibliography
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
Table 1 Total Pipeline Products
Table 3 Pipeline Products by Type
Table 7 Pipeline Products by Technique
Table 9 Pipeline Products by Application
Table 11 List of Companies
Table 14 3DBiopsy, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17 3D Biopsy Device - Product Status
Table 20 3D Biopsy Device - Product Description
Table 21 ActuatedMedical Pipeline Products & Ongoing Clinical Trials Overview
Table 23 The OsteoAccess System - Product Status
Table 25 The OsteoAccess System - Product Description
Figure 1 List of Pipeline Products
Figure 4 Ongoing Clinical Trial Pipeline Products by Type
Figure 6 Ongoing Clinical Trial Pipeline Products by Technique
Figure 8 Ongoing Clinical Trial Pipeline Products by Application
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.